Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
(f) Change in Control means: (a) the sale of all or substantially all of the assets of the Company, (b) the sale of more than fifty percent (50%) of the outstanding shares of any class of stock of the Company in a non-public sale, (c) the dissolution or liquidation of the Company, or (d) any merger or consolidation of the Company if, immediately after any such transaction, either (i) persons who were directors of the Company immediately prior to such transaction do not constitute at least a majority of the directors (or similar officials) of the surviving or purchasing entity, or (ii) Persons who hold a majority of the voting securities of the surviving or purchasing entity are not Persons who held a majority of the stock of the Company immediately prior to such transaction

We further examined nascent DNA degradation in PDS5B deficient cells expressing several RAD51 mutants, two of which (II3A and T131P) lack DNA strand exchange activity, with the remaining two (K133R and G151D) being proficient in stand exchange 36
I particularly appreciated its smoothing effect on pores and its gentle purifying effect
New York: MacGraw Hill, 31293149
Multimodal pain management approaches encourage patients to move early, which helps prevent complications such as deep vein thrombosis and supports normalization of bowel function